Shaping the Future of Eye Health with Groundbreaking, World-First Technology.
Technology-Driven Company established on 10 years of R&D
Introduction
Our company is an R&D-driven organization that develops ophthalmic diagnostic devices based on the world’s first goblet cell imaging technology, originally developed by a leading university research team in Korea. Leveraging AI-powered image analysis, we are building an integrated diagnostic platform capable of detecting not only ocular diseases such as dry eye but also a wide range of systemic conditions.
FOUNDING MEMBERS
CEO
K Y Kim
Former COO, Nanophilia
Former Researcher, CJ Corp.
B.S. & M.S., Hanyang Univ.
CTO
K H Kim
Current Prof., Dept. of Mech. Eng., POSTECH
Ph.D., Mech. Eng. MIT
B.S. & M.S., Seoul National Univ.
CSO
C H Yoon
Current Prof. of Ophth.,
Seoul National Univ. Hospital
Ph.D. in Medicine, Seoul National Univ.
Bachelor of Medicine
Seoul National Univ.
Advisor
M J Kim
Current Representative Dr., Hea-An Seoul Eye Clinic
Former Prof. of Ophth, Asan Medical Center
Former Director, Medical Device Development Center, Asan Medical Center
Ph.D. in Medicine, Ulsan Univ.
Bachelor of Medicine
Seoul National Univ.
History
2025.11
KIBO
Recognized as an Outstanding Participant in the 17th Cohort of KIBO Venture Camp Program
2025.07
KUKJE PHARM CO., LTD
Signing of an MOU
2025.07
MSS
Recognized as a Venture Company
2025.06
SAMSUNG
Selected for the Samsung Electronics Future Technology Development Program – Startup Mentoring Track
2025.06
POSTECH
Collaboration (Joint Research)
2025.05
K-BIO HEALTH
Regulatory Support Program Agreement signed
2025.04
KOITA
Certified R&D Center
2024.10
Corporate Establishment
2015
POSTECH
Research on Goblet Cell Imaging Technology